Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area Sort descending
    Country
    Application Due Date
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Diagnosis and Risk Factors for Invasive Mold Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    2025 Rheumatology Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area Sort descending
    Country
    Application Due Date
    Barriers to Adult Immunizations
    Release Date:
    Oral Anticoagulants (Pfizer and BMS)
    Release Date:
    Review Process:
    Extension Grant - Window 2
    Release Date:
    Smoking Cessation Conference
    Release Date:
    Adherence to Medications for Rheumatoid Arthritis
    Release Date:
    HCP Perceptions on Immunization
    Release Date:
    Advanced Renal Cell Carcinoma
    Release Date:
    Chronic Pain Care
    Release Date:
    Adolescent Immunization
    Release Date:
    Appropriate Immunizations in Rheumatoid Arthritis Patients
    Release Date:
    Appropriate use of Hormone Therapy in Postmenopausal Women
    Release Date:
    Antimicrobial Stewardship
    Release Date: